JP2015508056A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015508056A5 JP2015508056A5 JP2014554166A JP2014554166A JP2015508056A5 JP 2015508056 A5 JP2015508056 A5 JP 2015508056A5 JP 2014554166 A JP2014554166 A JP 2014554166A JP 2014554166 A JP2014554166 A JP 2014554166A JP 2015508056 A5 JP2015508056 A5 JP 2015508056A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- human
- pld4
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014554166A JP6118345B2 (ja) | 2012-01-31 | 2013-01-31 | 抗ホスホリパーゼｄ４抗体 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012018266 | 2012-01-31 | ||
| JP2012018266 | 2012-01-31 | ||
| PCT/JP2013/052781 WO2013115410A2 (en) | 2012-01-31 | 2013-01-31 | Anti-phospholipase d4 antibody |
| JP2014554166A JP6118345B2 (ja) | 2012-01-31 | 2013-01-31 | 抗ホスホリパーゼｄ４抗体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017058867A Division JP2017155045A (ja) | 2012-01-31 | 2017-03-24 | 抗ホスホリパーゼｄ４抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015508056A JP2015508056A (ja) | 2015-03-16 |
| JP2015508056A5 true JP2015508056A5 (enExample) | 2016-09-23 |
| JP6118345B2 JP6118345B2 (ja) | 2017-04-19 |
Family
ID=47748721
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014554166A Active JP6118345B2 (ja) | 2012-01-31 | 2013-01-31 | 抗ホスホリパーゼｄ４抗体 |
| JP2017058867A Pending JP2017155045A (ja) | 2012-01-31 | 2017-03-24 | 抗ホスホリパーゼｄ４抗体 |
| JP2018220873A Active JP6830471B2 (ja) | 2012-01-31 | 2018-11-27 | 抗ホスホリパーゼｄ４抗体 |
| JP2020180164A Active JP7244102B2 (ja) | 2012-01-31 | 2020-10-28 | 抗ホスホリパーゼｄ４抗体 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017058867A Pending JP2017155045A (ja) | 2012-01-31 | 2017-03-24 | 抗ホスホリパーゼｄ４抗体 |
| JP2018220873A Active JP6830471B2 (ja) | 2012-01-31 | 2018-11-27 | 抗ホスホリパーゼｄ４抗体 |
| JP2020180164A Active JP7244102B2 (ja) | 2012-01-31 | 2020-10-28 | 抗ホスホリパーゼｄ４抗体 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9944715B2 (enExample) |
| EP (2) | EP2809683B1 (enExample) |
| JP (4) | JP6118345B2 (enExample) |
| KR (1) | KR102098413B1 (enExample) |
| CN (2) | CN112442128B (enExample) |
| AU (2) | AU2013215886B2 (enExample) |
| CA (1) | CA2863009C (enExample) |
| DK (2) | DK2809683T3 (enExample) |
| ES (2) | ES2873035T3 (enExample) |
| HU (2) | HUE054362T2 (enExample) |
| IL (1) | IL233794B (enExample) |
| PL (2) | PL3431504T3 (enExample) |
| PT (1) | PT2809683T (enExample) |
| TR (1) | TR201819828T4 (enExample) |
| WO (1) | WO2013115410A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE054362T2 (hu) * | 2012-01-31 | 2021-09-28 | Sbi Biotech Co Ltd | Foszfolipáz D4 elleni antitest |
| SG11201600666SA (en) * | 2013-07-30 | 2016-02-26 | Sbi Biotech Co Ltd | Medicament comprising anti-phospholipase d4 antibody |
| CN109535254B (zh) * | 2013-12-24 | 2022-06-24 | 安斯泰来制药株式会社 | 抗人bdca-2抗体、其生产方法、多核苷酸、表达载体、宿主细胞及医药组合物 |
| JP2019509759A (ja) | 2016-01-14 | 2019-04-11 | ビーピーエス バイオサイエンス、インク．Ｂｐｓ Ｂｉｏｓｃｉｅｎｃｅ， Ｉｎｃ． | 抗ｐｄ−１抗体及びその使用 |
| JP6979976B2 (ja) * | 2016-03-10 | 2021-12-15 | ヴィエラ バイオ，インコーポレーテッド | Ｉｌｔ７結合分子及びその使用方法 |
| CN105624325B (zh) * | 2016-03-31 | 2019-06-11 | 北京泱深生物信息技术有限公司 | 肺腺癌的诊治标记物 |
| PE20210125A1 (es) * | 2017-10-14 | 2021-01-19 | Abbvie Inc | Conjugados de farmaco-anticuerpo activable anti-cd71 y metodos de uso de estos |
| CN110042123B (zh) * | 2019-01-07 | 2023-01-17 | 西北农林科技大学 | 一种通过诱导表达zfp57提高牛体细胞克隆效率的方法 |
| WO2021203013A2 (en) | 2020-04-03 | 2021-10-07 | Viela Bio, Inc. | Methods of treating immune mediated pulmonary injury |
| WO2025085746A1 (en) * | 2023-10-18 | 2025-04-24 | Immunorx Pharma Inc. | Humanized anti-s100a9 antibody |
| CN119120388A (zh) * | 2024-10-22 | 2024-12-13 | 江苏亲科生物研究中心有限公司 | 一种pdpfl单克隆抗体及其试剂盒的制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7098015B2 (en) * | 1999-06-11 | 2006-08-29 | Millennium Pharmaceuticals, Inc. | 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor |
| US20050058649A1 (en) | 2002-12-02 | 2005-03-17 | Landes Gregory M. | Antibodies directed to phospholipase A2 and uses thereof |
| AU2005256113B2 (en) * | 2004-07-09 | 2011-02-10 | Chugai Seiyaku Kabushiki Kaisha | Anti-glypican 3 antibody |
| HUE054362T2 (hu) * | 2012-01-31 | 2021-09-28 | Sbi Biotech Co Ltd | Foszfolipáz D4 elleni antitest |
| SG11201600666SA (en) * | 2013-07-30 | 2016-02-26 | Sbi Biotech Co Ltd | Medicament comprising anti-phospholipase d4 antibody |
-
2013
- 2013-01-31 HU HUE18188036A patent/HUE054362T2/hu unknown
- 2013-01-31 WO PCT/JP2013/052781 patent/WO2013115410A2/en not_active Ceased
- 2013-01-31 CN CN202011128007.3A patent/CN112442128B/zh active Active
- 2013-01-31 ES ES18188036T patent/ES2873035T3/es active Active
- 2013-01-31 EP EP13705843.4A patent/EP2809683B1/en active Active
- 2013-01-31 PT PT13705843T patent/PT2809683T/pt unknown
- 2013-01-31 JP JP2014554166A patent/JP6118345B2/ja active Active
- 2013-01-31 CA CA2863009A patent/CA2863009C/en active Active
- 2013-01-31 TR TR2018/19828T patent/TR201819828T4/tr unknown
- 2013-01-31 ES ES13705843.4T patent/ES2694165T3/es active Active
- 2013-01-31 US US14/375,266 patent/US9944715B2/en active Active
- 2013-01-31 DK DK13705843.4T patent/DK2809683T3/en active
- 2013-01-31 AU AU2013215886A patent/AU2013215886B2/en active Active
- 2013-01-31 HU HUE13705843A patent/HUE041552T2/hu unknown
- 2013-01-31 PL PL18188036T patent/PL3431504T3/pl unknown
- 2013-01-31 DK DK18188036.0T patent/DK3431504T3/da active
- 2013-01-31 PL PL13705843T patent/PL2809683T3/pl unknown
- 2013-01-31 KR KR1020147023620A patent/KR102098413B1/ko active Active
- 2013-01-31 EP EP18188036.0A patent/EP3431504B1/en active Active
- 2013-01-31 CN CN201380018285.5A patent/CN104284903B/zh active Active
-
2014
- 2014-07-24 IL IL233794A patent/IL233794B/en active IP Right Grant
-
2017
- 2017-03-24 JP JP2017058867A patent/JP2017155045A/ja active Pending
-
2018
- 2018-02-08 AU AU2018200934A patent/AU2018200934B2/en active Active
- 2018-03-02 US US15/910,206 patent/US10336834B2/en active Active
- 2018-11-27 JP JP2018220873A patent/JP6830471B2/ja active Active
-
2020
- 2020-10-28 JP JP2020180164A patent/JP7244102B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102022734B1 (ko) | 신규 조절제 및 용법 | |
| JP2014524733A5 (enExample) | ||
| KR101455447B1 (ko) | Ｍｕｃ１＊ 항체 | |
| CN110066336B (zh) | 抗cd47单克隆抗体、片段及其医药用途 | |
| RU2017118262A (ru) | АНТИТЕЛО ПРОТИВ ПРОТЕИНТИРОЗИНФОСФАТАЗЫ σ РЕЦЕПТОРНОГО ТИПА ЧЕЛОВЕКА | |
| JP2020535799A5 (enExample) | ||
| HRP20191697T1 (hr) | Vezujuće molekule za bcma i cd3 | |
| JP2021500916A5 (enExample) | ||
| JP2011510654A5 (enExample) | ||
| CN116801905A (zh) | Cd5抗体及其应用 | |
| RU2008129715A (ru) | Антитело против ilt17 | |
| IL273196B2 (en) | Claudin6 antibodies and methods of treating cancer | |
| US20250136687A1 (en) | Anti-human cd3 antibody and use thereof | |
| RU2009126766A (ru) | Антитела человека к дельта-подобному лиганду-4 человека | |
| RU2017137010A (ru) | Анти-сеасам6 антитела и их применения | |
| JP2018510636A5 (enExample) | ||
| JP2018535670A5 (enExample) | ||
| JP2011526493A5 (enExample) | ||
| US20240301085A1 (en) | Humanized gpc3 antibody and application thereof | |
| JP2016516400A5 (enExample) | ||
| EP4458854A1 (en) | Gprc5d antibody and application thereof | |
| RU2012137380A (ru) | Моноклональные антитела к cd44, предназначенные для применения при лечении плоскоклеточной карциномы головы и шеи | |
| RU2010119450A (ru) | Антитело против bst2 | |
| WO2022105914A1 (zh) | Cd70抗体及其应用 | |
| JP2013520984A5 (enExample) |